LNP200 NVR Pill - yellow capsule/oblong
Generic Name: iptacopan
Pill with imprint LNP200 NVR is Yellow, Capsule/Oblong and has been identified as Fabhalta 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Fabhalta is used in the treatment of Paroxysmal Nocturnal Hemoglobinuria; C3 Glomerulopathy; Immunoglobulin A Nephropathy and belongs to the drug class selective immunosuppressants. Fabhalta 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LNP200 NVR
Fabhalta
- Generic Name
- iptacopan
- Imprint
- LNP200 NVR
- Strength
- 200 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-1189
More about Fabhalta (iptacopan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.